Skip to main content
. Author manuscript; available in PMC: 2009 Dec 3.
Published in final edited form as: Ann Emerg Med. 2009 Sep 19;54(6):769–778.e1-5. doi: 10.1016/j.annemergmed.2009.07.027

Table 1.

Study Sample Characteristics

Characteristic Overall Cohort [n=2584] 30-Day Serious Event [n=173] No 30-Day Serious Event [n=2411] Missing Data
Demographics
 Age*
  60–69 32% 22% 33%
  70–79 38% 38% 38%
  80–89 26% 32% 26%
  >90 4% 9% 4%
 Male* 46% 59% 41%
 Non-White* 20% 12% 21% 7%
 Hispanic 12% 10% 12% 7%
Co-Morbidities
  Coronary Artery Disease 22% 25% 21%
  Congestive Heart Failure** 9% 17% 8%
  Ejection Fraction <40%* 1% 6% 1%
  Aortic Stenosis 1% 1% 1%
  Arrhythmia* 13% 30% 12%
  Pacemaker/AICD 5% 8% 5%
  Stroke 15% 20% 15%
  Prior Syncope in 30 Days 2% 2% 2%
  Diabetes 20% 23% 20%
  Hypertension 61% 61% 62%
  Dementia 9% 13% 9%
Symptoms
 Near-Syncope* 31% 20% 32%
 Chest Pain 7% 11% 7% 16%
 Shortness of Breath 8% 13% 7% 32%
 No Prodromal Symptoms** 16% 23% 16% 13%
Physical Exam
 Triage Vital Signs
  HR<60** 18% 17% 17% 11%
  HR 60–100 73% 70% 76%
  HR>100 7% 13% 7%
  SBP<90 2% 3% 2% 11%
  SBP 90–160 78% 72% 78%
  SBP>160 20% 26% 19%
 Cardiac Murmur 11% 14% 11% 12%
 Abnormal Neurologic Exam 4% 6% 4% 15%
 Major Traumatic Injury* 4% 8% 3%
Tests
 Abnormal ECG* 51% 71% 50% 5%
  Non-sinus Rhythm* 11% 10% 26%
  ST/T Changes* 23% 23% 32%
  Abnormal Intervals* 8% 8% 16%
  Ventricular Hypertrophy 10% 9% 12%
  Left Axis Deviation 14% 14% 15%
  Left Bundle Branch Block 4% 4% 4%
  Right Bundle Branch Block 7% 7% 11%
 Hematocrit<30 5% 5% 5% 14%
 Pyuria 7% 5% 7%
 Abnormal Troponin* 11% 25% 10% 30%
Admitted* 43% 86% 40%
*

Comparison between serious event and no-serious event groups: p<0.01

**

Comparison between serious event and no-serious event groups: p<0.05

Compared to Syncope

Weighted estimate- see methods section